Personal information

No personal information available

Activities

Collapse all

Employment (1)

A.C. Camargo Cancer Center: Sao Paulo, BR

2019-03-01 to present
Employment
Source: Self-asserted source
Fernando Campos

Education and qualifications (6)

European University of Madrid: Madrid, ES

2021-11-22 to 2022-10-31 | Master in Musculoskeletal Tumors
Education
Source: Self-asserted source
Fernando Campos

A.C. Camargo Cancer Center: Sao Paulo, Sao Paulo, BR

2016-03-01 to 2019-02-28 | Medical Oncology Residency (Medical Oncology)
Education
Source: Self-asserted source
Fernando Campos

University of Texas MD Anderson Cancer Center: TX, TX, US

2018-10-01 to 2018-10-30 | Observership (Sarcoma Medical Oncology)
Qualification
Source: Self-asserted source
Fernando Campos

University of Chicago: Chicago, IL, US

2018-06-01 to 2018-06-09 | Preceptorship (Cancer Genetics)
Qualification
Source: Self-asserted source
Fernando Campos

Hospital de Clínicas da Universidade Federal do Triângulo Mineiro: Uberaba, Minas Gerais, BR

2014-03-01 to 2016-02-28 | Internal Medicine Residency (Internal Medicine)
Education
Source: Self-asserted source
Fernando Campos

Universidade Federal do Triângulo Mineiro: Uberaba, MG, BR

2006-08-01 to 2012-07-31 | Bachelor of Medicine
Education
Source: Self-asserted source
Fernando Campos

Professional activities (4)

Sociedade Brasileira de Oncologia Clínica: São Paulo, BR

Membership
Source: Self-asserted source
Fernando Campos

European Society for Medical Oncology: Lugano, CH

Membership
Source: Self-asserted source
Fernando Campos

Connective Tissue Oncology Society: Lisbon, PT

Membership
Source: Self-asserted source
Fernando Campos

American Society of Clinical Oncology: Alexandria, Virginia, US

Membership
Source: Self-asserted source
Fernando Campos

Works (11)

Enhancing rare cancer care in developing countries through patient advocacy: insights from the Desmoid Tumor Brazilian Association

Therapeutic Advances in Medical Oncology
2025-01 | Journal article
DOI: 10.1177/17588359241309827
Contributors: Philippos Apolinario Costa; Carolina Menezes; Bruna Bianca Lopes David; Georgia Garofalo; Livia Prudente Barbieri; Fernando Campos
Source: check_circle
Crossref

Survival differences of patients with resected extraskeletal osteosarcoma receiving two different (neo)adjuvant chemotherapy regimens: a systematic review and meta-analysis

Clinical Oncology
2023-09 | Journal article
DOI: 10.1016/j.clon.2023.09.009
Contributors: Fernando Augusto Batista Campos; Raúl Téres Lleida; Ana Sebio Garcia; Bárbara Beltrame Bettim; Javier Martinez-Trufero
Source: check_circle
Crossref

An introduction to male breast cancer for urologists: epidemiology, diagnosis, principles of treatment, and special situations

International braz j urol
2022-10 | Journal article
DOI: 10.1590/s1677-5538.ibju.2021.0828
Part of ISSN: 1677-6119
Part of ISSN: 1677-5538
Contributors: Fabiana BA Makdissi; Silvana S. Santos; Almir Bitencourt; Fernando Augusto Batista Campos
Source: Self-asserted source
Fernando Campos

SELNET clinical practice guidelines for bone sarcoma

Critical Reviews in Oncology/Hematology
2022-06 | Journal article
DOI: 10.1016/j.critrevonc.2022.103685
Part of ISSN: 1040-8428
Contributors: JY Blay; E. Palmerini; J. Bollard; S. Aguiar; M. Angel; B. Araya; R. Badilla; D. Bernabeu; F. Campos; Caro-Sánchez CHS et al.
Source: Self-asserted source
Fernando Campos

Combination of ifosfamide and etoposide as a salvage regimen for previously treated soft tissue sarcomas: a retrospective single centre study

ecancermedicalscience
2022-03-03 | Journal article
DOI: 10.3332/ecancer.2022.1363
Part of ISSN: 1754-6605
Contributors: Luiz Fernando Ribeiro; Fernando Augusto Batista Campos; Celso Abdon Mello
Source: Self-asserted source
Fernando Campos

SELNET clinical practice guidelines for soft tissue sarcoma and GIST

Cancer Treatment Reviews
2022-01 | Journal article
DOI: 10.1016/j.ctrv.2021.102312
Contributors: J.Y. Blay; N. Hindi; J. Bollard; S. Aguiar, Jr.; M. Angel; B. Araya; R. Badilla; D. Bernabeu; F. Campos; C.H.S. Caro-Sánchez et al.
Source: check_circle
Crossref

HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer

Breast Cancer Research and Treatment
2021-11 | Journal article
DOI: 10.1007/s10549-021-06365-7
Part of ISSN: 0167-6806
Part of ISSN: 1573-7217
Source: Self-asserted source
Fernando Campos

Circulating Tumor Cells in Desmoid Tumors: New Perspectives

Frontiers in Oncology
2021-09-14 | Journal article
DOI: 10.3389/fonc.2021.622626
Part of ISSN: 2234-943X
Source: Self-asserted source
Fernando Campos

Genetic Landscape of Male Breast Cancer

Cancers
2021-07-15 | Journal article
DOI: 10.3390/cancers13143535
Contributors: Fernando Augusto Batista Campos; Etienne Rouleau; Giovana Tardin Torrezan; Dirce Maria Carraro; José Claudio Casali da Rocha; Higor Kassouf Mantovani; Leonardo Roberto da Silva; Cynthia Aparecida Bueno de Toledo Osório; Solange Moraes Sanches; Sandrine M. Caputo et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Desmoplastic Small Round Cell Tumor: A Review of Main Molecular Abnormalities and Emerging Therapy

Cancers
2021-01-28 | Journal article
DOI: 10.3390/cancers13030498
Contributors: Celso Abdon Mello; Fernando Augusto Batista Campos; Tiago Goss Santos; Maria Leticia Gobo Silva; Giovana Tardin Torrezan; Felipe D’Almeida Costa; Maria Nirvana Formiga; Ulisses Nicolau; Antonio Geraldo Nascimento; Cassia Silva et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Clinical Characteristics, Management, and Outcomes of 19 Nonpediatric Patients with Desmoplastic Small Round Cell Tumor: A Cohort of Brazilian Patients

Sarcoma
2020-10-28 | Journal article
DOI: 10.1155/2020/8713165
Contributors: Fernando Campos; Daniel L. Coutinho; Maria Letícia G. Silva; Ademar Lopes; Antônio Nascimento; Samuel Aguiar Júnior; Ulisses R. Nicolau; Maria Nirvana Formiga; Felipe D’Almeida Costa; Celso Mello et al.
Source: check_circle
Crossref
How many people are using ORCID?